180 related articles for article (PubMed ID: 29305002)
1. Dysregulated Myogenesis in Rhabdomyosarcoma.
Yu PY; Guttridge DC
Curr Top Dev Biol; 2018; 126():285-297. PubMed ID: 29305002
[TBL] [Abstract][Full Text] [Related]
2. Myogenesis and rhabdomyosarcoma the Jekyll and Hyde of skeletal muscle.
Saab R; Spunt SL; Skapek SX
Curr Top Dev Biol; 2011; 94():197-234. PubMed ID: 21295688
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis.
Novák J; Vinklárek J; Bienertová-Vašků J; Slabý O
Pediatr Blood Cancer; 2013 Nov; 60(11):1739-46. PubMed ID: 23813576
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality.
Rota R; Ciarapica R; Giordano A; Miele L; Locatelli F
Mol Cancer; 2011 Sep; 10():120. PubMed ID: 21943149
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development.
Cieśla M; Dulak J; Józkowicz A
Int J Biochem Cell Biol; 2014 Aug; 53():482-92. PubMed ID: 24831881
[TBL] [Abstract][Full Text] [Related]
6. MiRNAs as Players in Rhabdomyosarcoma Development.
Gasparini P; Ferrari A; Casanova M; Limido F; Massimino M; Sozzi G; Fortunato O
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752446
[TBL] [Abstract][Full Text] [Related]
7. Role of microRNAs in skeletal muscle development and rhabdomyosarcoma (review).
Ju H; Yang Y; Sheng A; Jiang X
Mol Med Rep; 2015 Jun; 11(6):4019-24. PubMed ID: 25633282
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
Zhang M; Zhu B; Davie J
J Biol Chem; 2015 Jan; 290(1):310-24. PubMed ID: 25404735
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of impaired differentiation in rhabdomyosarcoma.
Keller C; Guttridge DC
FEBS J; 2013 Sep; 280(17):4323-34. PubMed ID: 23822136
[TBL] [Abstract][Full Text] [Related]
10. Upstream CpG island methylation of the PAX3 gene in human rhabdomyosarcomas.
Kurmasheva RT; Peterson CA; Parham DM; Chen B; McDonald RE; Cooney CA
Pediatr Blood Cancer; 2005 Apr; 44(4):328-37. PubMed ID: 15602708
[TBL] [Abstract][Full Text] [Related]
11. A dysfunctional miR-1-TRPS1-MYOG axis drives ERMS by suppressing terminal myogenic differentiation.
Hüttner SS; Henze H; Elster D; Koch P; Anderer U; von Eyss B; von Maltzahn J
Mol Ther; 2023 Sep; 31(9):2612-2632. PubMed ID: 37452493
[TBL] [Abstract][Full Text] [Related]
12. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
[TBL] [Abstract][Full Text] [Related]
13. Wnt Signaling in Rhabdomyosarcoma - A Potential Targeted Therapy Option.
Chen E
Curr Drug Targets; 2016; 17(11):1245-51. PubMed ID: 26122033
[TBL] [Abstract][Full Text] [Related]
14. WT1 expression does not disrupt myogenic differentiation in C2C12 murine myoblasts or in human rhabdomyosarcoma.
Tiffin N; Williams RD; Robertson D; Hill S; Shipley J; Pritchard-Jones K
Exp Cell Res; 2003 Jul; 287(1):155-65. PubMed ID: 12799191
[TBL] [Abstract][Full Text] [Related]
15. Regulation of skeletal muscle development and disease by microRNAs.
Liu N; Bassel-Duby R
Results Probl Cell Differ; 2015; 56():165-90. PubMed ID: 25344671
[TBL] [Abstract][Full Text] [Related]
16. Recent Insights into Notch Signaling in Embryonal Rhabdomyosarcoma.
Conti B; Slemmons KK; Rota R; Linardic CM
Curr Drug Targets; 2016; 17(11):1235-44. PubMed ID: 26343114
[TBL] [Abstract][Full Text] [Related]
17. Decoding the 'embryonic' nature of embryonal rhabdomyosarcoma.
Lav R; Heera R; Cherian LM
J Dev Orig Health Dis; 2015 Jun; 6(3):163-8. PubMed ID: 25740270
[TBL] [Abstract][Full Text] [Related]
18. Genetic modeling of human rhabdomyosarcoma.
Linardic CM; Downie DL; Qualman S; Bentley RC; Counter CM
Cancer Res; 2005 Jun; 65(11):4490-5. PubMed ID: 15930263
[TBL] [Abstract][Full Text] [Related]
19. The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma.
Patel AG; Chen X; Huang X; Clay MR; Komorova N; Krasin MJ; Pappo A; Tillman H; Orr BA; McEvoy J; Gordon B; Blankenship K; Reilly C; Zhou X; Norrie JL; Karlstrom A; Yu J; Wodarz D; Stewart E; Dyer MA
Dev Cell; 2022 May; 57(10):1226-1240.e8. PubMed ID: 35483358
[TBL] [Abstract][Full Text] [Related]
20. From Nutrient to MicroRNA: a Novel Insight into Cell Signaling Involved in Skeletal Muscle Development and Disease.
Zhang Y; Yu B; He J; Chen D
Int J Biol Sci; 2016; 12(10):1247-1261. PubMed ID: 27766039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
